IDIQ award for clinical trial materials for virus vaccines with a maximum ordering value of $24,519,468.00

Active Indefinite Delivery Contract Awarded Last action

Contract number
75N93021D00018
Awardee
Awarding agency
Task orders
15 $12,450,115 obligated

Award facts

Opportunity
Combined order value
$12,450,115 Current and potential, with all options
Last date to order 81% complete
IDV ceiling 51% used
$24,519,468.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

The National Institute of Allergy and Infectious Diseases awarded an indefinite-delivery contract to Charles River Laboratories, Inc. with a ceiling of $24.519 million on February 23, 2021. This is a single-award IDIQ with no set-aside designation.

Work is performed at Charles River's facility in Wilmington, Massachusetts. The contract procures clinical trial materials for virus vaccines, including vaccine candidate preparation, characterization, and manufacturing support for respiratory and infectious disease research.

The period of performance runs from award through February 22, 2028. NAICS code 545 (All Other Animal Production) and PSC code 2,235 (Live Animals, Not Raised For Food) are primary categories.

Recent task-order activity under this IDIQ includes: a $5.243 million delivery order issued September 30, 2025, for preparation and characterization of five vaccine candidates; two delivery orders issued June 15, 2026, each valued at $339,743, for human metapneumovirus pediatric respiratory virus vaccine clinical trial materials (HMPV Lots #103 and #104, Task Orders 12 and 13, completing June 14, 2027); a $448,478 delivery order issued September 27, 2024, for influenza challenge virus; and a $433,606 delivery order issued July 25, 2022, for universal coronavirus vaccine development. All recent orders are firm fixed price and performed in Wilmington, Massachusetts.

Charles River operates as a vertically integrated prime contractor with minimal subcontracting in federal vaccine and clinical trial material work, leveraging incumbent relationships with NIAID and NIH institutes.

Task orders

Task order Ordering agency Obligated Awarded
Clinical trial materials for virus vaccines. Historic H3N2 and H10N7 influenza challenge viruses. Task order 15. 75N98026F00004 Office of Logisitics and Acquisition Operations (NIH) $1,006,390
Clinical trial materials for virus vaccines. Cgmp preparation of live denv-4 clinical lot. Task order 14. 75N98026F00003 Office of Logisitics and Acquisition Operations (NIH) $371,635
Clinical trial materials for virus vaccines. Clinical trial material for human metapneumovirus (hmpv) pediatric… 75N98026F00002 Office of Logisitics and Acquisition Operations (NIH) $339,743
Clinical trial materials for virus vaccines. Clinical trial material for human metapneumovirus (hmpv) pediatric… 75N98026F00001 Office of Logisitics and Acquisition Operations (NIH) $339,743
Preparation and characterization of five vaccine candidates 75N93025F00001 National Institute of Allergy and Infectious Diseases (NIH) $5,243,310
Influenza challenge virus; TO10 75N93024F00001 National Institute of Allergy and Infectious Diseases (NIH) $448,478
Clinical trial materials for virus vaccines 75N93023F00003 National Institute of Allergy and Infectious Diseases (NIH) $296,136
Clinical trial materials for virus vaccines 75N93023F00002 National Institute of Allergy and Infectious Diseases (NIH) $374,769
Clinical trial materials for virus vaccines 75N93023F00001 National Institute of Allergy and Infectious Diseases (NIH) $525,976
Production of an agmk cell bank 75N93022F00004 National Institute of Allergy and Infectious Diseases (NIH) $76,257
Universal influenza vaccine 75N93022F00003 National Institute of Allergy and Infectious Diseases (NIH) $2,006,234
Universal coronavirus vaccine 75N93022F00002 National Institute of Allergy and Infectious Diseases (NIH) $433,606
Coronavirus challenge virus 75N93022F00001 National Institute of Allergy and Infectious Diseases (NIH) $403,775
Manufacture of clinical trial material for b/HPIV3/hmpv-f, lots PIV#115A and PIV#116 75N93021F00002 National Institute of Allergy and Infectious Diseases (NIH) $452,810
Clinical trial materials for virus vaccines 75N93021F00001 National Institute of Allergy and Infectious Diseases (NIH) $131,255
Show all 15

Transactions

Action Obligated Date
Other Administrative Action P00004 $0
Other Administrative Action P00003 $0
Change Order P00002 · Clinical trial materials for virus vaccines $0
Change Order P00001 $0
Original award $0

Quick answers

Who was awarded contract 75N93021D00018?

75N93021D00018 was awarded to Charles River Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on February 23, 2021.

How much is contract 75N93021D00018 worth?

Orders under 75N93021D00018 have obligated $12,450,115. 75N93021D00018's own ceiling is $24,519,468.

How many orders have been placed under contract 75N93021D00018?

15 orders have been placed under 75N93021D00018, the latest on September 1, 2026.

Who can order from contract 75N93021D00018?

75N93021D00018 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 75N93021D00018 competed?

The extent of competition for 75N93021D00018 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV